Soleno Therapeutics Income Statement (2013-2026) | SLNO

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.03B0.07B0.09B0.09B
Cost of Revenue (Quarter)
0.00B0.00B0.00B0.00B
Gross Profit (Quarter)
0.03B0.06B0.09B0.09B
Operating items
Research & Development (Quarter)
0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.03B0.02B0.01B0.01B0.01B0.01B0.01B
Selling, General & Administrative (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.05B0.04B0.03B0.03B0.03B0.04B0.05B
Other Operating Expenses (Quarter)
0.00B0.00B-0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Operating Expenses (Quarter)
0.01B0.01B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.02B0.02B0.08B0.06B0.05B0.04B0.04B0.05B0.06B
Operating Income (Quarter)
-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B-0.02B-0.08B-0.06B-0.05B-0.01B0.02B0.04B0.03B
EBIT (Quarter)
-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B-0.02B-0.08B-0.06B-0.05B-0.01B0.02B0.04B0.03B
Non-operating items
Interest & Investment Income (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.00B
Other Non Operating Income (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Non Operating Income (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Net income details
EBT (Quarter)
-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B-0.02B-0.08B-0.06B-0.04B-0.00B0.03B0.04B0.03B
Tax Provisions (Quarter)
0.00B
Profit After Tax (Quarter)
-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B-0.02B-0.08B-0.06B-0.04B-0.00B0.03B0.04B0.03B
Income from Continuing Operations (Quarter)
-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B-0.02B-0.08B-0.06B-0.04B-0.00B0.03B0.04B0.03B
Consolidated Net Income (Quarter)
-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B-0.02B-0.08B-0.06B-0.04B-0.00B0.03B0.04B0.03B
Income towards Parent Company (Quarter)
-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B-0.02B-0.08B-0.06B-0.04B-0.00B0.03B0.04B0.03B
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B-0.02B-0.08B-0.06B-0.04B-0.00B0.03B0.04B0.03B
Additional items
EPS (Basic) (Quarter)
-0.14-1.53-0.53-1.07-0.72-0.65-0.56-0.88-0.81-0.950.29-0.59-0.57-1.83-1.30-0.95-0.090.490.850.60
EPS (Weighted Average and Diluted) (Quarter)
-0.14-1.53-0.53-1.07-0.72-0.65-0.56-0.88-0.81-0.950.29-0.59-0.57-1.83-1.30-0.95-0.090.470.840.59
Shares Outstanding (Weighted Average) (Quarter)
0.00B0.01B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.02B0.04B0.04B0.04B0.04B0.05B0.05B0.05B0.00B0.05B
Shares Outstanding (Diluted Average) (Quarter)
0.08B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.02B0.04B0.04B0.04B0.04B0.05B0.05B0.05B0.05B
EBITDA (Quarter)
-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.02B-0.02B-0.08B-0.06B-0.04B-0.00B0.03B0.04B0.03B
Interest Expenses (Quarter)
0.00B0.00B0.00B0.00B0.00B
Tax Rate (Quarter)
10.13%